Human placentas from IUGR pregnancies express reduced levels of NFE2, leading to upregulation of GCM1 and excessive development of the syncytium (82), suggesting that similar molecular pathways operate in the establishment of the human placental IHM and may contribute to IUGR when disrupted. The gene discussed is GCM1; the disease is fetal growth restriction.